Trial | NCT01319734  Report issue

Title

Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
Phase 1 Study of Randomized Clinical Trial Comparing Vitamin C Supplementation Plus Oral Hypoglycemic Drugs Versus Hypoglycemic Drugs Alone on Serum Selenium, Zinc, Copper and Malondialdehyde Levels in Type 2 Diabetes Mellitus and Its Microvascular Complications

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Unknown status

  • Study Participants

    50
Null hypothesis:

No significant effect of vitamin C 500 mg Supplementation on the severity of micro-vascular complications of type 2 Diabetes Mellitus (DM).

Alternative hypothesis:

There is a significant effect of vitamin C 500mg supplementation on the severity of the micro-vascular complications of type 2DM.
Study Started
Feb 28
2011
Primary Completion
Dec 31
2015
Anticipated
Last Update
Sep 18
2013
Estimate

Dietary Supplement Vitamin C

Vitamin C supplementation 500mg

Drug glyburide

this group receiving glyburide 5 mg alone

Vitamin C supplementation plus oral hypoglycemic agents arm Experimental

This group will receive vitamin C supplementation 500mg daily for one month and then assessment will done for the patients.

Type 2DM patients receiving oral hypoglycemic agents alone Active Comparator

this group is the control group who receive oral hypoglycemic agents alone

Criteria 

Inclusion Criteria:

clinical diagnosis of type 2DM
patients in good health
receiving oral hypoglycemic drugs

Exclusion Criteria:

Insulin dependent diabetes
receiving vitamin complex
smoking
renal disease
liver disease
No Results Posted